JPMorgan raised the firm’s price target on Omnicell (OMCL) to $44 from $37 and keeps a Neutral rating on the shares. The firm updated the company’s model post the Q3 report.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.